The HIP Self-management Study (NCT06297148) | Clinical Trial Compass
Active — Not RecruitingNot Applicable
The HIP Self-management Study
Norway110 participantsStarted 2024-03-12
Plain-language summary
The HIPS-study will be an observer blinded, single-centre, parallel-group randomized controlled trial (RCT).
The main purpose of the study is:
1. To investigate the clinical effectiveness of a self- management program versus usual care for patients with greater trochanteric pain syndrome (GTPS).
* H0: There is no difference between a self-management program and usual care on pain and function in patients with GTPS.
* H1: There is a difference between a self-management program and usual care on pain and function in patients with GTPS.
2. To investigate if self-management is more cost-effective than usual care in the treatment of patients with GTPS.
Participants will be randomly allocated into one of two groups: 1) self-management program or 2) usual care.
Follow-up will be at 3-, 6- and 12-months.
Who can participate
Age range
18 Years – 70 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Participants between 18 and 70 years of age
* History of lateral hip pain \> 3 months
* Reported average pain intensity the last week ≥ 3 on a numeric rating scale
* Lateral hip pain is the main complaint
* Pain on palpation of the greater trochanter region
* In addition, lateral hip pain on at least one of the following tests:
* Single leg stance test: standing 30 seconds on the affected leg
* FADER: passive stretch/compression of gluteus medius/minimus
* FADER-R: static muscle test with resistance to internal hip rotation
* ADD: passive stretch to hip adduction in sidelying
* ADD-R: resisted hip abduction in sidelying
* FABER (Patrick's) test
A positive test is defined as a spontaneous reproduction of the participant's lateral hip pain. In participants with bilateral lateral hip pain, the worst hip will be included, and the presence of bilateral pain will be documented.
Exclusion Criteria:
* Significant back pain causing referred pain to the lateral hip
* Clinical signs of radiculopathy
* Symptomatic osteoarthritis
* Other hip joint pathologies
* History of trauma or surgery on the affected side
* Pregnancy or post-partum pelvic pain (under 12 months since birth)
* Active cancer
* Not able to write, read, and comprehend Norwegian (without the use of an interpreter)
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Victorian Institute of Sport Assessment Gluteal Questionnaire (VISA-G)